Quantcast

Posts related to ‘Healthcare’

Does DaVita Acquisition Make Warren Buffett Rethink His Kidney Dialysis Bet?

Posted: May 21, 2012 at 10:05 am

DaVita Inc. (NYSE: DVA) is facing a bit of a drag on its announcement that it is spending some $4.4 billion to acquire HealthCare Partners.  This is a transformative deal ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Posted: May 18, 2012 at 7:47 am

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

IPO Filing From KYTHERA: Fighting The Double Chin

Posted: May 17, 2012 at 8:58 am

KYTHERA Biopharmaceuticals, Inc. has just joined in with the companies which have filed to come public via an initial public offering.  The common stock plans to be listed on The ...
Read Full Story »

Rosetta Genomics Share Offering: No Good Deeds Go Unpunished

Posted: May 17, 2012 at 7:34 am

Rosetta Genomics, Ltd. (NASDAQ: ROSG) was an exponential winner on Wednesday due to getting a Medicare reimbursement ruling in its favor.  The company had announced that the Medicare Administrative Contractor ...
Read Full Story »

Rosetta Genomics Joins Exponential Explosion Club on Medicare Coverage

Posted: May 16, 2012 at 10:25 am

Rosetta Genomics Ltd. (NASDAQ: ROSG) is not often in the news, but it is in the news a big way now.  The microRNA-based molecular diagnostic test maker has announced that Novitas, ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Posted: May 10, 2012 at 12:02 pm

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

Herbalife Sinks on Lack of Info (HLF, NUS)

Posted: May 3, 2012 at 2:33 pm

Shares of Herbalife Ltd. (NYSE: HLF) are trading at about 9x average daily volume today following some weak answers on the company’s conference call yesterday. The network marketer of nutrition ...
Read Full Story »

Allscripts Plunges on Perfect Storm of Bad News (MDRX)

Posted: April 27, 2012 at 12:29 pm

Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) fired its board chairman, saw three directors leave in protest, and announced the resignation of the company’s CFO all at the same time that ...
Read Full Story »

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Posted: April 27, 2012 at 9:15 am

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company.  It is one of the biggest public merger rumors out there. At least that is the belief ...
Read Full Story »

Social Security, Medicare Still Going Broke

Posted: April 23, 2012 at 3:23 pm

The annual report of the Trustees of the Social Security and Medicare trust funds has been released, and no matter what one believes about how the US should provide a ...
Read Full Story »

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Posted: April 23, 2012 at 2:54 pm

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to acquire the company.  With another small-cap to mid-cap biotech and ...
Read Full Story »

The Most Popular Plastic Surgeries in America

Posted: April 23, 2012 at 6:40 am

The total number of cosmetic procedures performed in the United States by plastic surgeons has nearly doubled since 2000. Surgeries are on the decline, but minimally invasive procedures -- such ...
Read Full Story »

$4.4 Billion Health Care Merger (CHSI, ESRX, SXCI)

Posted: April 18, 2012 at 9:20 am

Health care benefits manager SXC Health Solutions Corp. (NASDAQ: SXCI) has agreed to acquire competitor Catalyst Health Solutions Inc. (NASDAQ: CHSI) in a deal valued at $4.4 billion. According to ...
Read Full Story »

VioPharma Runs Into FDA & FTC Troubles Over Staph Drug (VPHM)

Posted: April 10, 2012 at 8:35 am

ViroPharma Incorporated (NASDAQ: VPHM) is getting crushed on news that the Food & Drug Administration has denied the petition filed by ViroPharma on March 17, 2006 related to the FDA's ...
Read Full Story »

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

Posted: April 10, 2012 at 7:11 am

VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ...
Read Full Story »